Martinez-Garcia M, Oscullo G, Garcia-Ortega A, Matera M, Rogliani P, Cazzola M
Drugs. 2022; 82(14):1453-1468.
PMID: 36264441
PMC: 9626424.
DOI: 10.1007/s40265-022-01785-1.
Lee H, Jin K, Lee H, Lee J, Park T, Heo E
Int J Chron Obstruct Pulmon Dis. 2022; 17:2301-2315.
PMID: 36159655
PMC: 9503700.
DOI: 10.2147/COPD.S372735.
Choi J, Jeong K, Park Y, Yu I, Lee S, Lee M
Int J Chron Obstruct Pulmon Dis. 2021; 16:3229-3237.
PMID: 34858023
PMC: 8629914.
DOI: 10.2147/COPD.S332151.
Mkorombindo T, Dransfield M
Clin Chest Med. 2020; 41(3):475-484.
PMID: 32800200
PMC: 7521468.
DOI: 10.1016/j.ccm.2020.05.006.
Borghardt J, Kloft C, Sharma A
Can Respir J. 2018; 2018:2732017.
PMID: 30018677
PMC: 6029458.
DOI: 10.1155/2018/2732017.
Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.
Restrepo M, Sibila O, Anzueto A
Tuberc Respir Dis (Seoul). 2018; 81(3):187-197.
PMID: 29962118
PMC: 6030662.
DOI: 10.4046/trd.2018.0030.
Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids.
Liu Y, DiMango E, Bucovsky M, Agarwal S, Nishiyama K, Guo X
Osteoporos Int. 2018; 29(9):2121-2127.
PMID: 29947865
PMC: 6138454.
DOI: 10.1007/s00198-018-4591-9.
Growth perturbations from stimulant medications and inhaled corticosteroids.
Richardson E, Seibert T, Uli N
Transl Pediatr. 2017; 6(4):237-247.
PMID: 29184805
PMC: 5682374.
DOI: 10.21037/tp.2017.09.14.
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
Janson C, Stratelis G, Miller-Larsson A, Harrison T, Larsson K
Int J Chron Obstruct Pulmon Dis. 2017; 12:3055-3064.
PMID: 29089754
PMC: 5654780.
DOI: 10.2147/COPD.S143656.
The Skeletal Effects of Inhaled Glucocorticoids.
Sutter S, Stein E
Curr Osteoporos Rep. 2016; 14(3):106-13.
PMID: 27091558
PMC: 4861637.
DOI: 10.1007/s11914-016-0308-1.
Systemic effects of inhaled corticosteroids: an overview.
Pandya D, Puttanna A, Balagopal V
Open Respir Med J. 2015; 8:59-65.
PMID: 25674175
PMC: 4319197.
DOI: 10.2174/1874306401408010059.
Adrenal crisis caused by inhaled fluticasone in an adolescent with cystic fibrosis and advanced hepatopathy: a case report.
Denne C, Vogl-Voswinckel A, Gruebl A, Burdach S
Case Rep Pulmonol. 2012; 2012:913574.
PMID: 23056987
PMC: 3465889.
DOI: 10.1155/2012/913574.
Achieving symptom control in patients with moderate asthma.
Weir N, Levine S
Clin Med Insights Circ Respir Pulm Med. 2012; 6:1-11.
PMID: 22259262
PMC: 3256747.
DOI: 10.4137/CCRPM.S5100.
Rapid nongenomic actions of inhaled corticosteroids on long-acting β(2)-agonist transport in the airway.
Horvath G, Mendes E, Schmid N, Schmid A, Conner G, Fregien N
Pulm Pharmacol Ther. 2011; 24(6):654-9.
PMID: 21914487
PMC: 3220932.
DOI: 10.1016/j.pupt.2011.08.002.
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
Chung K, Caramori G, Adcock I
Eur J Clin Pharmacol. 2009; 65(9):853-71.
PMID: 19557399
DOI: 10.1007/s00228-009-0682-z.
Safety of intranasal corticosteroids in acute rhinosinusitis.
Demoly P
Am J Otolaryngol. 2009; 29(6):403-13.
PMID: 19144302
PMC: 7115254.
DOI: 10.1016/j.amjoto.2007.11.004.
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide.
Braido F, Lagasio C, Piroddi I, Baiardini I, Canonica G
Ther Clin Risk Manag. 2008; 4(2):353-61.
PMID: 18728855
PMC: 2504079.
DOI: 10.2147/tcrm.s1266.
Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.
Mortimer K, Tattersfield A, Tang Y, Wu K, Lewis S, Hochhaus G
Br J Clin Pharmacol. 2007; 64(4):439-44.
PMID: 17711540
PMC: 2048552.
DOI: 10.1111/j.1365-2125.2007.02856.x.
Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.
Mortimer K, Harrison T, Tang Y, Wu K, Lewis S, Sahasranaman S
Br J Clin Pharmacol. 2006; 62(4):412-9.
PMID: 16995862
PMC: 1885155.
DOI: 10.1111/j.1365-2125.2006.02712.x.
Epigenetics and airways disease.
Adcock I, Ford P, Ito K, Barnes P
Respir Res. 2006; 7:21.
PMID: 16460559
PMC: 1382219.
DOI: 10.1186/1465-9921-7-21.
